Perceptive Advisors’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.2M Hold
833,333
0.06% 82
2025
Q4
$3.09M Hold
833,333
0.06% 101
2025
Q3
$11.8M Hold
833,333
0.34% 53
2025
Q2
$16M Hold
833,333
0.59% 39
2025
Q1
$9.22M Buy
+833,333
New +$9.94M 0.33% 56
2023
Q4
Sell
-44,132
Closed -$7.2M 110
2023
Q3
$7.2M Sell
44,132
-16,025
-27% -$3.78M 0.24% 65
2023
Q2
$19.7M Sell
60,157
-12,471
-17% -$3.8M 0.57% 49
2023
Q1
$20M Hold
72,628
0.59% 43
2022
Q4
$28.1M Sell
72,628
-5,281
-7% -$1.49M 0.79% 39
2022
Q3
$18.6M Buy
77,909
+11,327
+17% +$3.03M 0.54% 46
2022
Q2
$14.8M Sell
66,582
-58,978
-47% -$25.4M 0.46% 48
2022
Q1
$85.5M Buy
125,560
+1,334
+1% +$803K 1.71% 17
2021
Q4
$85.9M Sell
124,226
-8,483
-6% -$6.27M 1.32% 21
2021
Q3
$98.4M Sell
132,709
-26,460
-17% -$18M 1.43% 18
2021
Q2
$119M Hold
159,169
1.55% 17
2021
Q1
$130M Sell
159,169
-30,686
-16% -$23.7M 1.64% 18
2020
Q4
$162M Hold
189,855
1.74% 16
2020
Q3
$142M Buy
+189,855
New +$156M 2.08% 15

Other funds holding OM

Perceptive Advisors's OM Position: Q1 2026 in Review

Perceptive Advisors held its Outset Medical (OM) position steady in Q1 2026 at 833,333 shares worth $3.2M. The position accounts for 0.06% of the portfolio, ranked #82.

Perceptive Advisors first reported a position in OM in Q3 2020 and has held it in 18 quarters since. The position peaked at $162M in Q4 2020. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Perceptive Advisors held 833,333 shares of Outset Medical worth $3.2M as of Q1 2026.
  • Perceptive Advisors left its Outset Medical share count unchanged in Q1 2026.
  • Outset Medical made up 0.06% of Perceptive Advisors's portfolio in Q1 2026, its #82 holding.
  • Perceptive Advisors first reported a position in Outset Medical in Q3 2020 and has held it in 18 quarters since.
  • Perceptive Advisors's Outset Medical position peaked at $162M in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Perceptive Advisors's 13F filing for Q1 2026, filed 15 May 2026.